MANGOCEUTICALS, INC. (MGRX): M&A transaction — Mangoceuticals acquires Smokeless Technology IP, enters oral pouch market with 1.6M shares and royalty

MANGOCEUTICALS, INC.

Acquired IP from Smokeless Technology Corp. for 1,600,000 restricted shares of MGRX common stock and 10% royalty on gross pouch product sales.
Appointed Tim Corkum, former Philip Morris and JUUL executive, as President of new pouch subsidiary via Consulting Agreement with Strategem Solutions for 120,000 shares and $12,500/month.
CEO Jacob Cohen received amended employment: base salary raised to $420,000, bonus of 3,192,906 shares of M&P subsidiary stock, and increased allowances.
Pouch market projected to exceed $37 billion by 2032; Mangoceuticals plans to leverage distribution and telemedicine platform for new product lines.

item 1.01 item 2.01 item 3.02 item 5.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

MANGOCEUTICALS, INC. completed an acquisition involving Smokeless Technology Corp. (closed 2025-04-24).

Action: acquisition
Counterparty: Smokeless Technology Corp.
Closing: 2025-04-24

Exact text from the filing

The IP Purchase Agreement, and the purchase of the Purchased IP, closed on April 24, 2025, upon the parties entry into the IP Purchase Agreement

View on SEC.gov

5 m&a transactions filed in the last 30 days. Browse all m&a transactions →

MANGOCEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001641172-25-006122

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.